81(R) SB 449 - Enrolled version

�
�
�	S.B.�No.�449

�
�
�
�	AN ACT
�	relating to the penalty group classification of certain controlled
�	substances.
�	��BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
�	��SECTION�1.��Section 481.102, Health and Safety Code, is
�	amended to read as follows:
�	��Sec.�481.102.��PENALTY GROUP 1. Penalty Group 1 consists of:
�	��(1)��the following opiates, including their isomers,
�	esters, ethers, salts, and salts of isomers, esters, and ethers,
�	unless specifically excepted, if the existence of these isomers,
�	esters, ethers, and salts is possible within the specific chemical
�	designation:
�	��Alfentanil;
�	��Allylprodine;
�	��Alphacetylmethadol;
�	��Benzethidine;
�	��Betaprodine;
�	��Clonitazene;
�	��Diampromide;
�	��Diethylthiambutene;
�	��Difenoxin not listed in Penalty Group 3 or 4;
�	��Dimenoxadol;
�	��Dimethylthiambutene;
�	��Dioxaphetyl butyrate;
�	��Dipipanone;
�	��Ethylmethylthiambutene;
�	��Etonitazene;
�	��Etoxeridine;
�	��Furethidine;
�	��Hydroxypethidine;
�	��Ketobemidone;
�	��Levophenacylmorphan;
�	��Meprodine;
�	��Methadol;
�	��Moramide;
�	��Morpheridine;
�	��Noracymethadol;
�	��Norlevorphanol;
�	��Normethadone;
�	��Norpipanone;
�	��Phenadoxone;
�	��Phenampromide;
�	��Phenomorphan;
�	��Phenoperidine;
�	��Piritramide;
�	��Proheptazine;
�	��Properidine;
�	��Propiram;
�	��Sufentanil;
�	��Tilidine; and
�	��Trimeperidine;
�	��(2)��the following opium derivatives, their salts,
�	isomers, and salts of isomers, unless specifically excepted, if the
�	existence of these salts, isomers, and salts of isomers is possible
�	within the specific chemical designation:
�	��Acetorphine;
�	��Acetyldihydrocodeine;
�	��Benzylmorphine;
�	��Codeine methylbromide;
�	��Codeine-N-Oxide;
�	��Cyprenorphine;
�	��Desomorphine;
�	��Dihydromorphine;
�	��Drotebanol;
�	��Etorphine, except hydrochloride salt;
�	��Heroin;
�	��Hydromorphinol;
�	��Methyldesorphine;
�	��Methyldihydromorphine;
�	��Monoacetylmorphine;
�	��Morphine methylbromide;
�	��Morphine methylsulfonate;
�	��Morphine-N-Oxide;
�	��Myrophine;
�	��Nicocodeine;
�	��Nicomorphine;
�	��Normorphine;
�	��Pholcodine; and
�	��Thebacon;
�	��(3)��the following substances, however produced,
�	except those narcotic drugs listed in another group:
�	��(A)��Opium and opiate not listed in Penalty Group
�	3 or 4, and a salt, compound, derivative, or preparation of opium or
�	opiate, other than thebaine derived butorphanol, nalmefene and its
�	salts, naloxone and its salts, and naltrexone and its salts, but
�	including:
�	��Codeine not listed in Penalty Group 3 or 4;
�	��Dihydroetorphine;
�	��Ethylmorphine not listed in Penalty Group 3
�	or 4;
�	��Granulated opium;
�	��Hydrocodone not listed in Penalty Group 3;
�	��Hydromorphone;
�	��Metopon;
�	��Morphine not listed in Penalty Group 3;
�	��Opium extracts;
�	��Opium fluid extracts;
�	��Oripavine;
�	��Oxycodone;
�	��Oxymorphone;
�	��Powdered opium;
�	��Raw opium;
�	��Thebaine; and
�	��Tincture of opium;
�	��(B)��a salt, compound, isomer, derivative, or
�	preparation of a substance that is chemically equivalent or
�	identical to a substance described by Paragraph (A), other than the
�	isoquinoline alkaloids of opium;
�	��(C)��Opium poppy and poppy straw;
�	��(D)��Cocaine, including:
�	��(i)��its salts, its optical, position, and
�	geometric isomers, and the salts of those isomers;
�	��(ii)��coca leaves and a salt, compound,
�	derivative, or preparation of coca leaves;
�	��(iii)��a salt, compound, derivative, or
�	preparation of a salt, compound, or derivative that is chemically
�	equivalent or identical to a substance described by Subparagraph
�	(i) or (ii), other than decocainized coca leaves or extractions of
�	coca leaves that do not contain cocaine or ecgonine; and
�	��(E)��concentrate of poppy straw, meaning the crude
�	extract of poppy straw in liquid, solid, or powder form that
�	contains the phenanthrine alkaloids of the opium poppy;
�	��(4)��the following opiates, including their isomers,
�	esters, ethers, salts, and salts of isomers, if the existence of
�	these isomers, esters, ethers, and salts is possible within the
�	specific chemical designation:
�	��Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-
�	phenethyl)-4-piperidinyl]-N-phenylacetamide);
�	��Alpha-methylthiofentanyl (N-[1-methyl-2-(2-
�	thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
�	��Alphaprodine;
�	��Anileridine;
�	��Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-
�	phenethyl)-4-piperidinyl] -N-phenylpropanamide);
�	��Beta-hydroxy-3-methylfentanyl;
�	��Bezitramide;
�	��Carfentanil;
�	��Dihydrocodeine not listed in Penalty Group 3 or 4;
�	��Diphenoxylate not listed in Penalty Group 3 or 4;
�	��Fentanyl or alpha-methylfentanyl, or any other
�	derivative of Fentanyl;
�	��Isomethadone;
�	��Levomethorphan;
�	��Levorphanol;
�	��Metazocine;
�	��Methadone;
�	��Methadone-Intermediate, 4-cyano-2-dimethylamino-
�	4, 4-diphenyl butane;
�	��3-methylfentanyl(N-[3-methyl-1-(2-phenylethyl)-
�	4-piperidyl]-N-phenylpropanamide);
�	��3-methylthiofentanyl(N-[3-methyl-1-(2-thienyl)
�	ethyl-4-piperidinyl]-N-phenylpropanamide);
�	��Moramide-Intermediate, 2-methyl-3-morpholino-1,
�	1-diphenyl-propane-carboxylic acid;
�	��Para-fluorofentanyl(N-(4-fluorophenyl)-N-1-(2-
�	phenylethyl)-4-piperidinylpropanamide);
�	��PEPAP (1-(2-phenethyl)-4-phenyl-4-
�	acetoxypiperidine);
�	��Pethidine (Meperidine);
�	��Pethidine-Intermediate-A, 4-cyano-1-methyl-4-
�	phenylpiperidine;
�	��Pethidine-Intermediate-B, ethyl-4-
�	phenylpiperidine-4 carboxylate;
�	��Pethidine-Intermediate-C, 1-methyl-4-
�	phenylpiperidine-4-carboxylic acid;
�	��Phenazocine;
�	��Piminodine;
�	��Racemethorphan;
�	��Racemorphan;
�	��Remifentanil; and
�	��Thiofentanyl(N-phenyl-N-[1-(2-thienyl)ethyl-4-pi
�	peridinyl]-propanamide);
�	��(5)��Flunitrazepam (trade or other name: Rohypnol);
�	��(6)��Methamphetamine, including its salts, optical
�	isomers, and salts of optical isomers;
�	��(7)��Phenylacetone and methylamine, if possessed
�	together with intent to manufacture methamphetamine;
�	��(8)��Phencyclidine, including its salts;
�	��(9)��Gamma hydroxybutyric acid (some trade or other
�	names: gamma hydroxybutyrate, GHB), including its salts; and
�	��(10)��Ketamine.
�	��SECTION�2.��Subsection (a), Section 481.103, Health and
�	Safety Code, is amended to read as follows:
�	��(a)��Penalty Group 2 consists of:
�	��(1)��any quantity of the following hallucinogenic
�	substances, their salts, isomers, and salts of isomers, unless
�	specifically excepted, if the existence of these salts, isomers,
�	and salts of isomers is possible within the specific chemical
�	designation:
�	��alpha-ethyltryptamine;
�	��alpha-methyltryptamine;
�	��4-bromo-2, 5-dimethoxyamphetamine (some trade or
�	other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine;
�	4-bromo-2, 5-DMA);
�	��4-bromo-2, 5-dimethoxyphenethylamine;
�	��Bufotenine (some trade and other names: 3-(beta-
�	Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5-
�	indolol; N, N-dimethylserotonin; 5-hydroxy-N, N-
�	dimethyltryptamine; mappine);
�	��Diethyltryptamine (some trade and other names: N,
�	N-Diethyltryptamine, DET);
�	��2, 5-dimethoxyamphetamine (some trade or other
�	names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA);
�	��2, 5-dimethoxy-4-ethylamphetamine (trade or other
�	name: DOET);
�	��2, 5-dimethoxy-4-(n)-propylthiophenethylamine
�	(trade or other name: 2C-T-7);
�	��Dimethyltryptamine ( trade or other name: DMT);
�	��Dronabinol (synthetic) in sesame oil and
�	encapsulated in a soft gelatin capsule in a U.S. Food and Drug
�	Administration approved drug product (some trade or other names for
�	Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9-
�	trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9-
�	(trans)- tetrahydrocannabinol);
�	��Ethylamine Analog of Phencyclidine (some trade or
�	other names: N-ethyl-1-phenylcyclohexylamine, (1-
�	phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine,
�	cyclohexamine, PCE);
�	��Ibogaine (some trade or other names: 7-Ethyl-6,
�	6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H-
�	pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.);
�	��Mescaline;
�	��5-methoxy-N, N-diisopropyltryptamine;
�	��5-methoxy-3, 4-methylenedioxy amphetamine;
�	��4-methoxyamphetamine (some trade or other names:
�	4-methoxy-alpha-methylphenethylamine; paramethoxyamphetamine;
�	PMA);
�	��1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP,
�	PPMP);
�	��4-methyl-2, 5-dimethoxyamphetamine (some trade
�	and other names: 4-methyl-2, 5-dimethoxy-alpha-
�	methylphenethylamine; "DOM"; "STP");
�	��3,4-methylenedioxy methamphetamine (MDMA, MDM);
�	��3,4-methylenedioxy amphetamine;
�	��3,4-methylenedioxy N-ethylamphetamine (Also
�	known as N-ethyl MDA);
�	��Nabilone (Another name for nabilone: (+)-trans-
�	3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6,
�	6-dimethyl-9H-dibenzo[b,d] pyran-9-one;
�	��N-benzylpiperazine (some trade or other names:
�	BZP; 1-benzylpiperazine);
�	��N-ethyl-3-piperidyl benzilate;
�	��N-hydroxy-3,4-methylenedioxyamphetamine (Also
�	known as N-hydroxy MDA);
�	��4-methylaminorex;
�	��N-methyl-3-piperidyl benzilate;
�	��Parahexyl (some trade or other names: 3-Hexyl-1-
�	hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d]
�	pyran; Synhexyl);
�	��1-Phenylcyclohexylamine;
�	��1-Piperidinocyclohexanecarbonitrile (PCC);
�	��Psilocin;
�	��Psilocybin;
�	��Pyrrolidine Analog of Phencyclidine (some trade
�	or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP);
�	��Tetrahydrocannabinols, other than marihuana, and
�	synthetic equivalents of the substances contained in the plant, or
�	in the resinous extractives of Cannabis, or synthetic substances,
�	derivatives, and their isomers with similar chemical structure and
�	pharmacological activity such as:
�	��delta-1 cis or trans tetrahydrocannabinol,
�	and their optical isomers;
�	��delta-6 cis or trans tetrahydrocannabinol,
�	and their optical isomers;
�	��delta-3, 4 cis or trans
�	tetrahydrocannabinol, and its optical isomers;
�	��compounds of these structures, regardless of
�	numerical designation of atomic positions, since nomenclature of
�	these substances is not internationally standardized;
�	��Thiophene Analog of Phencyclidine (some trade or
�	other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl
�	Analog of Phencyclidine; TPCP, TCP);
�	��1-pyrrolidine (some trade or other name: TCPy);
�	��1-(3-trifluoromethylphenyl)piperazine (trade or
�	other name: TFMPP); and
�	��3,4,5-trimethoxy amphetamine;
�	��(2)��Phenylacetone (some trade or other names:
�	Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl
�	ketone); and
�	��(3)��unless specifically excepted or unless listed in
�	another Penalty Group, a material, compound, mixture, or
�	preparation that contains any quantity of the following substances
�	having a potential for abuse associated with a depressant or
�	stimulant effect on the central nervous system:
�	��Aminorex (some trade or other names: aminoxaphen;
�	2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5-
�	phenyl-2-oxazolamine);
�	��Amphetamine, its salts, optical isomers, and
�	salts of optical isomers;
�	��Cathinone (some trade or other names: 2-amino-1-
�	phenyl-1-propanone, alpha-aminopropiophenone, 2-
�	aminopropiophenone);
�	��Etorphine Hydrochloride;
�	��Fenethylline and its salts;
�	��Lisdexamfetamine, including its salts, isomers,
�	and salts of isomers;
�	��Mecloqualone and its salts;
�	��Methaqualone and its salts;
�	��Methcathinone (some trade or other names: 2-
�	methylamino-propiophenone; alpha-(methylamino)propriophenone;
�	2-(methylamino)-1-phenylpropan-1-one; alpha-N-
�	methylaminopropriophenone; monomethylpropion; ephedrone, N-
�	methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR
�	1431);
�	��N-Ethylamphetamine, its salts, optical isomers,
�	and salts of optical isomers; and
�	��N,N-dimethylamphetamine (some trade or other
�	names: N,N,alpha-trimethylbenzeneethaneamine;
�	N,N,alpha-trimethylphenethylamine), its salts, optical isomers,
�	and salts of optical isomers.
�	��SECTION�3.��Subsection (a), Section 481.104, Health and
�	Safety Code, is amended to read as follows:
�	��(a)��Penalty Group 3 consists of:
�	��(1)��a material, compound, mixture, or preparation that
�	contains any quantity of the following substances having a
�	potential for abuse associated with a stimulant effect on the
�	central nervous system:
�	��Methylphenidate and its salts; and
�	��Phenmetrazine and its salts;
�	��(2)��a material, compound, mixture, or preparation that
�	contains any quantity of the following substances having a
�	potential for abuse associated with a depressant effect on the
�	central nervous system:
�	��a substance that contains any quantity of a
�	derivative of barbituric acid, or any salt of a derivative of
�	barbituric acid not otherwise described by this subsection;
�	��a compound, mixture, or preparation containing
�	amobarbital, secobarbital, pentobarbital, or any salt of any of
�	these, and one or more active medicinal ingredients that are not
�	listed in any penalty group;
�	��a suppository dosage form containing amobarbital,
�	secobarbital, pentobarbital, or any salt of any of these drugs, and
�	approved by the United States Food and Drug Administration for
�	marketing only as a suppository;
�	��Alprazolam;
�	��Amobarbital;
�	��Bromazepam;
�	��Camazepam;
�	��Chlordiazepoxide;
�	��Chlorhexadol;
�	��Clobazam;
�	��Clonazepam;
�	��Clorazepate;
�	��Clotiazepam;
�	��Cloxazolam;
�	��Delorazepam;
�	��Diazepam;
�	��Estazolam;
�	��Ethyl loflazepate;
�	��Fludiazepam;
�	��Flurazepam;
�	��Glutethimide;
�	��Halazepam;
�	��Haloxzolam;
�	��Ketazolam;
�	��Loprazolam;
�	��Lorazepam;
�	��Lormetazepam;
�	��Lysergic acid, including its salts, isomers, and
�	salts of isomers;
�	��Lysergic acid amide, including its salts,
�	isomers, and salts of isomers;
�	��Mebutamate;
�	��Medazepam;
�	��Methyprylon;
�	��Midazolam;
�	��Nimetazepam;
�	��Nitrazepam;
�	��Nordiazepam;
�	��Oxazepam;
�	��Oxazolam;
�	��Pentazocine, its salts, derivatives, or compounds
�	or mixtures thereof;
�	��Pentobarbital;
�	��Pinazepam;
�	��Prazepam;
�	��Quazepam;
�	��Secobarbital;
�	��Sulfondiethylmethane;
�	��Sulfonethylmethane;
�	��Sulfonmethane;
�	��Temazepam;
�	��Tetrazepam;
�	��Tiletamine and zolazepam in combination, and its
�	salts. (some trade or other names for a tiletamine-zolazepam
�	combination product: Telazol, for tiletamine: 2-(ethylamino)-
�	2-(2-thienyl)-cyclohexanone, and for zolazepam: 4-(2-
�	fluorophenyl)-6, 8-dihydro-1,3,8,-trimethylpyrazolo-[3,4-
�	e](1,4)-d diazepin-7(1H)-one, flupyrazapon);
�	��Triazolam;
�	��Zaleplon; [~~and~~]
�	��Zolpidem; and
�	��Zopiclone;
�	��(3)��Nalorphine;
�	��(4)��a material, compound, mixture, or preparation
�	containing limited quantities of the following narcotic drugs, or
�	any of their salts:
�	��not more than 1.8 grams of codeine, or any of its
�	salts, per 100 milliliters or not more than 90 milligrams per dosage
�	unit, with an equal or greater quantity of an isoquinoline alkaloid
�	of opium;
�	��not more than 1.8 grams of codeine, or any of its
�	salts, per 100 milliliters or not more than 90 milligrams per dosage
�	unit, with one or more active, nonnarcotic ingredients in
�	recognized therapeutic amounts;
�	��not more than 300 milligrams of dihydrocodeinone
�	(hydrocodone), or any of its salts, per 100 milliliters or not more
�	than 15 milligrams per dosage unit, with a fourfold or greater
�	quantity of an isoquinoline alkaloid of opium;
�	��not more than 300 milligrams of dihydrocodeinone
�	(hydrocodone), or any of its salts, per 100 milliliters or not more
�	than 15 milligrams per dosage unit, with one or more active,
�	nonnarcotic ingredients in recognized therapeutic amounts;
�	��not more than 1.8 grams of dihydrocodeine, or any
�	of its salts, per 100 milliliters or not more than 90 milligrams per
�	dosage unit, with one or more active, nonnarcotic ingredients in
�	recognized therapeutic amounts;
�	��not more than 300 milligrams of ethylmorphine, or
�	any of its salts, per 100 milliliters or not more than 15 milligrams
�	per dosage unit, with one or more active, nonnarcotic ingredients
�	in recognized therapeutic amounts;
�	��not more than 500 milligrams of opium per 100
�	milliliters or per 100 grams, or not more than 25 milligrams per
�	dosage unit, with one or more active, nonnarcotic ingredients in
�	recognized therapeutic amounts;
�	��not more than 50 milligrams of morphine, or any of
�	its salts, per 100 milliliters or per 100 grams with one or more
�	active, nonnarcotic ingredients in recognized therapeutic amounts;
�	and
�	��not more than 1 milligram of difenoxin and not
�	less than 25 micrograms of atropine sulfate per dosage unit;
�	��(5)��a material, compound, mixture, or preparation that
�	contains any quantity of the following substances:
�	��Barbital;
�	��Chloral betaine;
�	��Chloral hydrate;
�	��Ethchlorvynol;
�	��Ethinamate;
�	��Meprobamate;
�	��Methohexital;
�	��Methylphenobarbital (Mephobarbital);
�	��Paraldehyde;
�	��Petrichloral; and
�	��Phenobarbital;
�	��(6)��Peyote, unless unharvested and growing in its
�	natural state, meaning all parts of the plant classified
�	botanically as Lophophora, whether growing or not, the seeds of the
�	plant, an extract from a part of the plant, and every compound,
�	manufacture, salt, derivative, mixture, or preparation of the
�	plant, its seeds, or extracts;
�	��(7)��unless listed in another penalty group, a
�	material, compound, mixture, or preparation that contains any
�	quantity of the following substances having a stimulant effect on
�	the central nervous system, including the substance's salts,
�	optical, position, or geometric isomers, and salts of the
�	substance's isomers, if the existence of the salts, isomers, and
�	salts of isomers is possible within the specific chemical
�	designation:
�	��Benzphetamine;
�	��Cathine [(+)-norpseudoephedrine];
�	��Chlorphentermine;
�	��Clortermine;
�	��Diethylpropion;
�	��Fencamfamin;
�	��Fenfluramine;
�	��Fenproporex;
�	��Mazindol;
�	��Mefenorex;
�	��Modafinil;
�	��Pemoline (including organometallic complexes and
�	their chelates);
�	��Phendimetrazine;
�	��Phentermine;
�	��Pipradrol;
�	��Sibutramine; and
�	��SPA [(-)-1-dimethylamino-1,2-diphenylethane];
�	��(8)��unless specifically excepted or unless listed in
�	another penalty group, a material, compound, mixture, or
�	preparation that contains any quantity of the following substance,
�	including its salts:
�	��Dextropropoxyphene (Alpha-(+)-4-dimethylamino-
�	1,2-diphenyl-3-methyl-2-propionoxybutane); and
�	��(9)��an anabolic steroid, including any drug or
�	hormonal substance, or any substance that is chemically or
�	pharmacologically related to testosterone, other than an estrogen,
�	progestin, dehydroepiandrosterone, or corticosteroid, and promotes
�	muscle growth, including the following drugs and substances and any
�	salt, ester, or ether of the following drugs and substances:
�	��Androstanediol;
�	��Androstanedione;
�	��Androstenediol;
�	��Androstenedione;
�	��Bolasterone;
�	��Boldenone;
�	��Calusterone;
�	��[~~Chlorotestosterone (4-chlortestosterone);~~]
�	��Clostebol;
�	��Dehydrochlormethyltestosterone;
�	��Delta-1-dihydrotestosterone;
�	��Dihydrotestosterone (4-dihydrotestosterone);
�	��Drostanolone;
�	��Ethylestrenol;
�	��Fluoxymesterone;
�	��Formebulone;
�	��Furazabol;
�	��13beta-ethyl-17beta-hydroxygon-4-en-3-one;
�	��4-hydroxytestosterone;
�	��4-hydroxy-19-nortestosterone;
�	��Mestanolone;
�	��Mesterolone;
�	��Methandienone;
�	��[~~Methandranone;~~]
�	��Methandriol;
�	��[~~Methandrostenolone;~~]
�	��Methenolone;
�	��17alpha-methyl-3beta, 17 beta-dihydroxy-5alpha-
�	androstane;
�	��17alpha-methyl-3alpha, 17 beta-dihydroxy-5alpha-
�	androstane;
�	��17alpha-methyl-3beta, 17beta-dihydroxyandrost-4-
�	ene;
�	��17alpha-methyl-4-hydroxynandrolone;
�	��Methyldienolone;
�	��Methyltestosterone;
�	��Methyltrienolone;
�	��17alpha-methyl-delta-1-dihydrotestosterone;
�	��Mibolerone;
�	��Nandrolone;
�	��Norandrostenediol;
�	��Norandrostenedione;
�	��Norbolethone;
�	��Norclostebol;
�	��Norethandrolone;
�	��Normethandrolone;
�	��Oxandrolone;
�	��Oxymesterone;
�	��Oxymetholone;
�	��[~~Stanolone;~~]
�	��Stanozolol;
�	��Stenbolone;
�	��Testolactone;
�	��Testosterone;
�	��Tetrahydrogestrinone; and
�	��Trenbolone.
�	��SECTION�4.��The change in law made by this Act applies only
�	to an offense committed on or after the effective date of this Act.
�	An offense committed before the effective date of this Act is
�	covered by the law in effect when the offense was committed, and the
�	former law is continued in effect for that purpose. For purposes of
�	this section, an offense was committed before the effective date of
�	this Act if any element of the offense was committed before that
�	date.
�	��SECTION�5.��This Act takes effect September 1, 2009.
�
�
�
�
�
�	______________________________	______________________________
�	��President of the Senate	Speaker of the House��
�
�	��I hereby certify that S.B.�No.�449 passed the Senate on
�	May�7,�2009, by the following vote:��Yeas�31, Nays�0.
�
�
�	______________________________
�	Secretary of the Senate��
�
�	��I hereby certify that S.B.�No.�449 passed the House on
�	May�27,�2009, by the following vote:��Yeas�148, Nays�0, one
�	present not voting.
�
�
�	______________________________
�	Chief Clerk of the House��
�
�
�
�	Approved:
�
�	______________________________�
�	��Date
�
�
�	______________________________�
�	��Governor